Guerbet SA
Guerbet SA GUERF Peers
See (GUERF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GUERF | $22.25 | N/A | 281.03M | 8.19 | $2.72 | N/A |
| SRTOY | $22.76 | +13.70% | 221.48B | 94.85 | $0.24 | +0.16% |
| ESLOF | $282.69 | -1.81% | 129.11B | 49.08 | $5.76 | +1.41% |
| ESLOY | $139.59 | -1.52% | 126.98B | 48.47 | $2.88 | +1.04% |
| MECNY | $88.63 | N/A | 107.62B | N/A | N/A | N/A |
| SSSGY | $42.51 | N/A | 82.76B | 137.13 | $0.31 | +0.41% |
| SOAGY | $52.30 | +0.79% | 81.18B | 168.71 | $0.31 | +0.15% |
| HOCPF | $127.14 | N/A | 43.58B | 30.78 | $4.13 | +0.85% |
| HOCPY | $121.15 | -2.53% | 41.53B | 29.69 | $4.08 | +0.42% |
| TRUMY | $19.12 | +1.27% | 28.20B | 32.97 | $0.58 | +0.30% |
Stock Comparison
GUERF vs SRTOY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SRTOY has a market cap of 221.48B. Regarding current trading prices, GUERF is priced at $22.25, while SRTOY trades at $22.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SRTOY's P/E ratio is 94.85. In terms of profitability, GUERF's ROE is N/A, compared to SRTOY's ROE of +0.05%. Regarding short-term risk, GUERF is less volatile compared to SRTOY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs ESLOF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, ESLOF has a market cap of 129.11B. Regarding current trading prices, GUERF is priced at $22.25, while ESLOF trades at $282.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas ESLOF's P/E ratio is 49.08. In terms of profitability, GUERF's ROE is N/A, compared to ESLOF's ROE of +0.06%. Regarding short-term risk, GUERF is less volatile compared to ESLOF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs ESLOY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, ESLOY has a market cap of 126.98B. Regarding current trading prices, GUERF is priced at $22.25, while ESLOY trades at $139.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas ESLOY's P/E ratio is 48.47. In terms of profitability, GUERF's ROE is N/A, compared to ESLOY's ROE of +0.06%. Regarding short-term risk, GUERF is less volatile compared to ESLOY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs MECNY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, MECNY has a market cap of 107.62B. Regarding current trading prices, GUERF is priced at $22.25, while MECNY trades at $88.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas MECNY's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to MECNY's ROE of +0.02%. Regarding short-term risk, GUERF and MECNY have similar daily volatility (0.00).
GUERF vs SSSGY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SSSGY has a market cap of 82.76B. Regarding current trading prices, GUERF is priced at $22.25, while SSSGY trades at $42.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SSSGY's P/E ratio is 137.13. In terms of profitability, GUERF's ROE is N/A, compared to SSSGY's ROE of +0.05%. Regarding short-term risk, GUERF is less volatile compared to SSSGY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs SOAGY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SOAGY has a market cap of 81.18B. Regarding current trading prices, GUERF is priced at $22.25, while SOAGY trades at $52.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SOAGY's P/E ratio is 168.71. In terms of profitability, GUERF's ROE is N/A, compared to SOAGY's ROE of +0.05%. Regarding short-term risk, GUERF is less volatile compared to SOAGY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs HOCPF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, HOCPF has a market cap of 43.58B. Regarding current trading prices, GUERF is priced at $22.25, while HOCPF trades at $127.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas HOCPF's P/E ratio is 30.78. In terms of profitability, GUERF's ROE is N/A, compared to HOCPF's ROE of +0.15%. Regarding short-term risk, GUERF is less volatile compared to HOCPF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs HOCPY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, HOCPY has a market cap of 41.53B. Regarding current trading prices, GUERF is priced at $22.25, while HOCPY trades at $121.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas HOCPY's P/E ratio is 29.69. In terms of profitability, GUERF's ROE is N/A, compared to HOCPY's ROE of +0.15%. Regarding short-term risk, GUERF is less volatile compared to HOCPY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs TRUMY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, TRUMY has a market cap of 28.20B. Regarding current trading prices, GUERF is priced at $22.25, while TRUMY trades at $19.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TRUMY's P/E ratio is 32.97. In terms of profitability, GUERF's ROE is N/A, compared to TRUMY's ROE of +0.07%. Regarding short-term risk, GUERF is less volatile compared to TRUMY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs RSMDF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, RSMDF has a market cap of 26.18B. Regarding current trading prices, GUERF is priced at $22.25, while RSMDF trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas RSMDF's P/E ratio is 24.72. In terms of profitability, GUERF's ROE is N/A, compared to RSMDF's ROE of +0.25%. Regarding short-term risk, GUERF is less volatile compared to RSMDF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs TRUMF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, TRUMF has a market cap of 26.04B. Regarding current trading prices, GUERF is priced at $22.25, while TRUMF trades at $17.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TRUMF's P/E ratio is 30.65. In terms of profitability, GUERF's ROE is N/A, compared to TRUMF's ROE of +0.07%. Regarding short-term risk, GUERF and TRUMF have similar daily volatility (0.00).
GUERF vs SDMHF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SDMHF has a market cap of 23.53B. Regarding current trading prices, GUERF is priced at $22.25, while SDMHF trades at $241.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SDMHF's P/E ratio is 101.17. In terms of profitability, GUERF's ROE is N/A, compared to SDMHF's ROE of +0.05%. Regarding short-term risk, GUERF and SDMHF have similar daily volatility (0.00).
GUERF vs CLPBF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, CLPBF has a market cap of 22.29B. Regarding current trading prices, GUERF is priced at $22.25, while CLPBF trades at $99.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CLPBF's P/E ratio is 32.37. In terms of profitability, GUERF's ROE is N/A, compared to CLPBF's ROE of +0.30%. Regarding short-term risk, GUERF is less volatile compared to CLPBF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs CLPBY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, CLPBY has a market cap of 21.63B. Regarding current trading prices, GUERF is priced at $22.25, while CLPBY trades at $9.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CLPBY's P/E ratio is 31.83. In terms of profitability, GUERF's ROE is N/A, compared to CLPBY's ROE of +0.30%. Regarding short-term risk, GUERF is less volatile compared to CLPBY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs SAUHY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SAUHY has a market cap of 21.33B. Regarding current trading prices, GUERF is priced at $22.25, while SAUHY trades at $13.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SAUHY's P/E ratio is 38.23. In terms of profitability, GUERF's ROE is N/A, compared to SAUHY's ROE of +0.14%. Regarding short-term risk, GUERF is less volatile compared to SAUHY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs SAUHF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SAUHF has a market cap of 21.32B. Regarding current trading prices, GUERF is priced at $22.25, while SAUHF trades at $133.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SAUHF's P/E ratio is 38.31. In terms of profitability, GUERF's ROE is N/A, compared to SAUHF's ROE of +0.14%. Regarding short-term risk, GUERF is less volatile compared to SAUHF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs SARTF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SARTF has a market cap of 16.31B. Regarding current trading prices, GUERF is priced at $22.25, while SARTF trades at $212.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SARTF's P/E ratio is 135.90. In terms of profitability, GUERF's ROE is N/A, compared to SARTF's ROE of +0.05%. Regarding short-term risk, GUERF is less volatile compared to SARTF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs OCPNF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, OCPNF has a market cap of 14.27B. Regarding current trading prices, GUERF is priced at $22.25, while OCPNF trades at $12.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas OCPNF's P/E ratio is 22.19. In terms of profitability, GUERF's ROE is N/A, compared to OCPNF's ROE of +0.10%. Regarding short-term risk, GUERF is less volatile compared to OCPNF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs SUVPF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SUVPF has a market cap of 12.19B. Regarding current trading prices, GUERF is priced at $22.25, while SUVPF trades at $198.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SUVPF's P/E ratio is 126.66. In terms of profitability, GUERF's ROE is N/A, compared to SUVPF's ROE of +0.05%. Regarding short-term risk, GUERF is less volatile compared to SUVPF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs FSPKF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, FSPKF has a market cap of 12.14B. Regarding current trading prices, GUERF is priced at $22.25, while FSPKF trades at $20.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas FSPKF's P/E ratio is 159.23. In terms of profitability, GUERF's ROE is N/A, compared to FSPKF's ROE of +0.10%. Regarding short-term risk, GUERF is less volatile compared to FSPKF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs SSMXY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SSMXY has a market cap of 10.84B. Regarding current trading prices, GUERF is priced at $22.25, while SSMXY trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SSMXY's P/E ratio is 27.16. In terms of profitability, GUERF's ROE is N/A, compared to SSMXY's ROE of +0.09%. Regarding short-term risk, GUERF is less volatile compared to SSMXY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs SSMXF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SSMXF has a market cap of 10.76B. Regarding current trading prices, GUERF is priced at $22.25, while SSMXF trades at $17.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SSMXF's P/E ratio is 26.95. In terms of profitability, GUERF's ROE is N/A, compared to SSMXF's ROE of +0.09%. Regarding short-term risk, GUERF is less volatile compared to SSMXF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs CNVVY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, CNVVY has a market cap of 7.21B. Regarding current trading prices, GUERF is priced at $22.25, while CNVVY trades at $14.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CNVVY's P/E ratio is 38.14. In terms of profitability, GUERF's ROE is N/A, compared to CNVVY's ROE of +0.16%. Regarding short-term risk, GUERF is less volatile compared to CNVVY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs CNVVF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, CNVVF has a market cap of 6.12B. Regarding current trading prices, GUERF is priced at $22.25, while CNVVF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CNVVF's P/E ratio is 33.33. In terms of profitability, GUERF's ROE is N/A, compared to CNVVF's ROE of +0.16%. Regarding short-term risk, GUERF is less volatile compared to CNVVF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs CZMWF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, CZMWF has a market cap of 6.06B. Regarding current trading prices, GUERF is priced at $22.25, while CZMWF trades at $69.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CZMWF's P/E ratio is 34.79. In terms of profitability, GUERF's ROE is N/A, compared to CZMWF's ROE of +0.07%. Regarding short-term risk, GUERF is less volatile compared to CZMWF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs CZMWY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, CZMWY has a market cap of 6.03B. Regarding current trading prices, GUERF is priced at $22.25, while CZMWY trades at $68.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CZMWY's P/E ratio is 34.62. In terms of profitability, GUERF's ROE is N/A, compared to CZMWY's ROE of +0.07%. Regarding short-term risk, GUERF is less volatile compared to CZMWY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs YPHDF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, YPHDF has a market cap of 5.70B. Regarding current trading prices, GUERF is priced at $22.25, while YPHDF trades at $417.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas YPHDF's P/E ratio is 63.72. In terms of profitability, GUERF's ROE is N/A, compared to YPHDF's ROE of +0.13%. Regarding short-term risk, GUERF is less volatile compared to YPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs FLMNY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, FLMNY has a market cap of 5.11B. Regarding current trading prices, GUERF is priced at $22.25, while FLMNY trades at $12.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas FLMNY's P/E ratio is 32.00. In terms of profitability, GUERF's ROE is N/A, compared to FLMNY's ROE of +0.15%. Regarding short-term risk, GUERF and FLMNY have similar daily volatility (0.00).
GUERF vs ADDLF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, ADDLF has a market cap of 4.93B. Regarding current trading prices, GUERF is priced at $22.25, while ADDLF trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas ADDLF's P/E ratio is 61.76. In terms of profitability, GUERF's ROE is N/A, compared to ADDLF's ROE of +0.06%. Regarding short-term risk, GUERF is less volatile compared to ADDLF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs AHICF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, AHICF has a market cap of 4.39B. Regarding current trading prices, GUERF is priced at $22.25, while AHICF trades at $16.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas AHICF's P/E ratio is 34.40. In terms of profitability, GUERF's ROE is N/A, compared to AHICF's ROE of +0.07%. Regarding short-term risk, GUERF and AHICF have similar daily volatility (0.00).
GUERF vs FLMNF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, FLMNF has a market cap of 3.93B. Regarding current trading prices, GUERF is priced at $22.25, while FLMNF trades at $46.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas FLMNF's P/E ratio is 24.74. In terms of profitability, GUERF's ROE is N/A, compared to FLMNF's ROE of +0.15%. Regarding short-term risk, GUERF is less volatile compared to FLMNF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs SHWGY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SHWGY has a market cap of 3.00B. Regarding current trading prices, GUERF is priced at $22.25, while SHWGY trades at $2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SHWGY's P/E ratio is 11.52. In terms of profitability, GUERF's ROE is N/A, compared to SHWGY's ROE of +0.09%. Regarding short-term risk, GUERF is less volatile compared to SHWGY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs SHWGF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SHWGF has a market cap of 2.98B. Regarding current trading prices, GUERF is priced at $22.25, while SHWGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SHWGF's P/E ratio is 11.00. In terms of profitability, GUERF's ROE is N/A, compared to SHWGF's ROE of +0.09%. Regarding short-term risk, GUERF is less volatile compared to SHWGF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs ANSLY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, ANSLY has a market cap of 2.91B. Regarding current trading prices, GUERF is priced at $22.25, while ANSLY trades at $80.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas ANSLY's P/E ratio is 24.62. In terms of profitability, GUERF's ROE is N/A, compared to ANSLY's ROE of +0.04%. Regarding short-term risk, GUERF is less volatile compared to ANSLY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs ANSLF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, ANSLF has a market cap of 2.62B. Regarding current trading prices, GUERF is priced at $22.25, while ANSLF trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas ANSLF's P/E ratio is 22.22. In terms of profitability, GUERF's ROE is N/A, compared to ANSLF's ROE of +0.06%. Regarding short-term risk, GUERF and ANSLF have similar daily volatility (0.00).
GUERF vs TCHBF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, TCHBF has a market cap of 2.55B. Regarding current trading prices, GUERF is priced at $22.25, while TCHBF trades at $200.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TCHBF's P/E ratio is 31.06. In terms of profitability, GUERF's ROE is N/A, compared to TCHBF's ROE of +0.07%. Regarding short-term risk, GUERF and TCHBF have similar daily volatility (0.00).
GUERF vs GRRMF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, GRRMF has a market cap of 2.52B. Regarding current trading prices, GUERF is priced at $22.25, while GRRMF trades at $73.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas GRRMF's P/E ratio is 28.33. In terms of profitability, GUERF's ROE is N/A, compared to GRRMF's ROE of +0.05%. Regarding short-term risk, GUERF and GRRMF have similar daily volatility (0.00).
GUERF vs TCGGY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, TCGGY has a market cap of 2.31B. Regarding current trading prices, GUERF is priced at $22.25, while TCGGY trades at $36.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TCGGY's P/E ratio is 27.91. In terms of profitability, GUERF's ROE is N/A, compared to TCGGY's ROE of +0.07%. Regarding short-term risk, GUERF is less volatile compared to TCGGY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs EKTAY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, EKTAY has a market cap of 2.09B. Regarding current trading prices, GUERF is priced at $22.25, while EKTAY trades at $5.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas EKTAY's P/E ratio is 18.89. In terms of profitability, GUERF's ROE is N/A, compared to EKTAY's ROE of +0.10%. Regarding short-term risk, GUERF is less volatile compared to EKTAY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs EKTAF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, EKTAF has a market cap of 1.89B. Regarding current trading prices, GUERF is priced at $22.25, while EKTAF trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas EKTAF's P/E ratio is 18.43. In terms of profitability, GUERF's ROE is N/A, compared to EKTAF's ROE of +0.10%. Regarding short-term risk, GUERF is less volatile compared to EKTAF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs BOEUF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, BOEUF has a market cap of 1.84B. Regarding current trading prices, GUERF is priced at $22.25, while BOEUF trades at $28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas BOEUF's P/E ratio is 147.37. In terms of profitability, GUERF's ROE is N/A, compared to BOEUF's ROE of +0.18%. Regarding short-term risk, GUERF is less volatile compared to BOEUF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs TGLVY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, TGLVY has a market cap of 1.77B. Regarding current trading prices, GUERF is priced at $22.25, while TGLVY trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TGLVY's P/E ratio is 88.29. In terms of profitability, GUERF's ROE is N/A, compared to TGLVY's ROE of +0.02%. Regarding short-term risk, GUERF is less volatile compared to TGLVY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs NPRRF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, NPRRF has a market cap of 1.50B. Regarding current trading prices, GUERF is priced at $22.25, while NPRRF trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas NPRRF's P/E ratio is 44.74. In terms of profitability, GUERF's ROE is N/A, compared to NPRRF's ROE of N/A. Regarding short-term risk, GUERF and NPRRF have similar daily volatility (0.00).
GUERF vs PBHDF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, PBHDF has a market cap of 1.12B. Regarding current trading prices, GUERF is priced at $22.25, while PBHDF trades at $19.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas PBHDF's P/E ratio is 12.74. In terms of profitability, GUERF's ROE is N/A, compared to PBHDF's ROE of +0.06%. Regarding short-term risk, GUERF and PBHDF have similar daily volatility (0.00).
GUERF vs TDVXF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, TDVXF has a market cap of 1.04B. Regarding current trading prices, GUERF is priced at $22.25, while TDVXF trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TDVXF's P/E ratio is 66.00. In terms of profitability, GUERF's ROE is N/A, compared to TDVXF's ROE of +0.39%. Regarding short-term risk, GUERF and TDVXF have similar daily volatility (0.00).
GUERF vs NNCSF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, NNCSF has a market cap of 956.34M. Regarding current trading prices, GUERF is priced at $22.25, while NNCSF trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas NNCSF's P/E ratio is 105.00. In terms of profitability, GUERF's ROE is N/A, compared to NNCSF's ROE of +0.07%. Regarding short-term risk, GUERF and NNCSF have similar daily volatility (0.00).
GUERF vs BITGF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, BITGF has a market cap of 910.16M. Regarding current trading prices, GUERF is priced at $22.25, while BITGF trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas BITGF's P/E ratio is 34.85. In terms of profitability, GUERF's ROE is N/A, compared to BITGF's ROE of +0.06%. Regarding short-term risk, GUERF is less volatile compared to BITGF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs KSRBF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, KSRBF has a market cap of 869.34M. Regarding current trading prices, GUERF is priced at $22.25, while KSRBF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas KSRBF's P/E ratio is 4.87. In terms of profitability, GUERF's ROE is N/A, compared to KSRBF's ROE of +0.03%. Regarding short-term risk, GUERF is less volatile compared to KSRBF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs SPMXF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SPMXF has a market cap of 550.31M. Regarding current trading prices, GUERF is priced at $22.25, while SPMXF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SPMXF's P/E ratio is -18.00. In terms of profitability, GUERF's ROE is N/A, compared to SPMXF's ROE of -0.05%. Regarding short-term risk, GUERF and SPMXF have similar daily volatility (0.00).
GUERF vs JNDOF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, JNDOF has a market cap of 531.00M. Regarding current trading prices, GUERF is priced at $22.25, while JNDOF trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas JNDOF's P/E ratio is 47.40. In terms of profitability, GUERF's ROE is N/A, compared to JNDOF's ROE of +0.20%. Regarding short-term risk, GUERF is less volatile compared to JNDOF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs HGYMF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, HGYMF has a market cap of 524.77M. Regarding current trading prices, GUERF is priced at $22.25, while HGYMF trades at $24.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas HGYMF's P/E ratio is 33.81. In terms of profitability, GUERF's ROE is N/A, compared to HGYMF's ROE of +0.02%. Regarding short-term risk, GUERF and HGYMF have similar daily volatility (0.00).
GUERF vs SAFLY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SAFLY has a market cap of 449.61M. Regarding current trading prices, GUERF is priced at $22.25, while SAFLY trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SAFLY's P/E ratio is 223.00. In terms of profitability, GUERF's ROE is N/A, compared to SAFLY's ROE of +0.00%. Regarding short-term risk, GUERF is less volatile compared to SAFLY. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs CLHLF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, CLHLF has a market cap of 365.45M. Regarding current trading prices, GUERF is priced at $22.25, while CLHLF trades at $61.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CLHLF's P/E ratio is 27.93. In terms of profitability, GUERF's ROE is N/A, compared to CLHLF's ROE of +0.12%. Regarding short-term risk, GUERF and CLHLF have similar daily volatility (0.00).
GUERF vs SAFLF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SAFLF has a market cap of 306.46M. Regarding current trading prices, GUERF is priced at $22.25, while SAFLF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SAFLF's P/E ratio is 12.67. In terms of profitability, GUERF's ROE is N/A, compared to SAFLF's ROE of +0.00%. Regarding short-term risk, GUERF is less volatile compared to SAFLF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs TSNLF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, TSNLF has a market cap of 252.35M. Regarding current trading prices, GUERF is priced at $22.25, while TSNLF trades at $5.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TSNLF's P/E ratio is 33.06. In terms of profitability, GUERF's ROE is N/A, compared to TSNLF's ROE of +0.21%. Regarding short-term risk, GUERF is less volatile compared to TSNLF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs OPSSF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, OPSSF has a market cap of 247.43M. Regarding current trading prices, GUERF is priced at $22.25, while OPSSF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas OPSSF's P/E ratio is -26.74. In terms of profitability, GUERF's ROE is N/A, compared to OPSSF's ROE of -0.17%. Regarding short-term risk, GUERF is less volatile compared to OPSSF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs EEOIF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, EEOIF has a market cap of 63.38M. Regarding current trading prices, GUERF is priced at $22.25, while EEOIF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas EEOIF's P/E ratio is -2.42. In terms of profitability, GUERF's ROE is N/A, compared to EEOIF's ROE of N/A. Regarding short-term risk, GUERF and EEOIF have similar daily volatility (0.00).
GUERF vs UEEC Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, UEEC has a market cap of 61.56M. Regarding current trading prices, GUERF is priced at $22.25, while UEEC trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas UEEC's P/E ratio is -23.94. In terms of profitability, GUERF's ROE is N/A, compared to UEEC's ROE of +1.31%. Regarding short-term risk, GUERF is less volatile compared to UEEC. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs IMTH Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, IMTH has a market cap of 31.51M. Regarding current trading prices, GUERF is priced at $22.25, while IMTH trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas IMTH's P/E ratio is -1.54. In terms of profitability, GUERF's ROE is N/A, compared to IMTH's ROE of +2.29%. Regarding short-term risk, GUERF is less volatile compared to IMTH. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs GVDI Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, GVDI has a market cap of 16.21M. Regarding current trading prices, GUERF is priced at $22.25, while GVDI trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas GVDI's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to GVDI's ROE of +0.00%. Regarding short-term risk, GUERF is less volatile compared to GVDI. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs OTCFF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, OTCFF has a market cap of 11.03M. Regarding current trading prices, GUERF is priced at $22.25, while OTCFF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas OTCFF's P/E ratio is -12.78. In terms of profitability, GUERF's ROE is N/A, compared to OTCFF's ROE of +18.74%. Regarding short-term risk, GUERF is less volatile compared to OTCFF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs YBGJ Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, YBGJ has a market cap of 10.66M. Regarding current trading prices, GUERF is priced at $22.25, while YBGJ trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas YBGJ's P/E ratio is -4.45. In terms of profitability, GUERF's ROE is N/A, compared to YBGJ's ROE of +3.46%. Regarding short-term risk, GUERF and YBGJ have similar daily volatility (0.00).
GUERF vs TEVNF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, TEVNF has a market cap of 7.43M. Regarding current trading prices, GUERF is priced at $22.25, while TEVNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TEVNF's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to TEVNF's ROE of +3.22%. Regarding short-term risk, GUERF is less volatile compared to TEVNF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs BLMHF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, BLMHF has a market cap of 5.22M. Regarding current trading prices, GUERF is priced at $22.25, while BLMHF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas BLMHF's P/E ratio is 1.56. In terms of profitability, GUERF's ROE is N/A, compared to BLMHF's ROE of N/A. Regarding short-term risk, GUERF and BLMHF have similar daily volatility (0.00).
GUERF vs PXMVF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, PXMVF has a market cap of 4.62M. Regarding current trading prices, GUERF is priced at $22.25, while PXMVF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas PXMVF's P/E ratio is -0.17. In terms of profitability, GUERF's ROE is N/A, compared to PXMVF's ROE of N/A. Regarding short-term risk, GUERF is less volatile compared to PXMVF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs RSCF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, RSCF has a market cap of 4.28M. Regarding current trading prices, GUERF is priced at $22.25, while RSCF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas RSCF's P/E ratio is -5.00. In terms of profitability, GUERF's ROE is N/A, compared to RSCF's ROE of +0.08%. Regarding short-term risk, GUERF is less volatile compared to RSCF. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs ECIA Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, ECIA has a market cap of 4.28M. Regarding current trading prices, GUERF is priced at $22.25, while ECIA trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas ECIA's P/E ratio is -9.00. In terms of profitability, GUERF's ROE is N/A, compared to ECIA's ROE of -0.33%. Regarding short-term risk, GUERF and ECIA have similar daily volatility (0.00).
GUERF vs MCDA Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, MCDA has a market cap of 4.24M. Regarding current trading prices, GUERF is priced at $22.25, while MCDA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas MCDA's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to MCDA's ROE of N/A. Regarding short-term risk, GUERF and MCDA have similar daily volatility (0.00).
GUERF vs CBSC Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, CBSC has a market cap of 4.17M. Regarding current trading prices, GUERF is priced at $22.25, while CBSC trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CBSC's P/E ratio is -3.70. In terms of profitability, GUERF's ROE is N/A, compared to CBSC's ROE of +1.52%. Regarding short-term risk, GUERF and CBSC have similar daily volatility (0.00).
GUERF vs NSTGQ Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, NSTGQ has a market cap of 3.31M. Regarding current trading prices, GUERF is priced at $22.25, while NSTGQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas NSTGQ's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to NSTGQ's ROE of N/A. Regarding short-term risk, GUERF is less volatile compared to NSTGQ. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs TUTH Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, TUTH has a market cap of 629427.00. Regarding current trading prices, GUERF is priced at $22.25, while TUTH trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas TUTH's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to TUTH's ROE of N/A. Regarding short-term risk, GUERF and TUTH have similar daily volatility (0.00).
GUERF vs OJSY Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, OJSY has a market cap of 454285.00. Regarding current trading prices, GUERF is priced at $22.25, while OJSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas OJSY's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to OJSY's ROE of N/A. Regarding short-term risk, GUERF and OJSY have similar daily volatility (0.00).
GUERF vs REMI Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, REMI has a market cap of 399920.00. Regarding current trading prices, GUERF is priced at $22.25, while REMI trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas REMI's P/E ratio is -2.00. In terms of profitability, GUERF's ROE is N/A, compared to REMI's ROE of -0.08%. Regarding short-term risk, GUERF is less volatile compared to REMI. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs PDMI Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, PDMI has a market cap of 324879.00. Regarding current trading prices, GUERF is priced at $22.25, while PDMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas PDMI's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to PDMI's ROE of +0.19%. Regarding short-term risk, GUERF and PDMI have similar daily volatility (0.00).
GUERF vs WHSI Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, WHSI has a market cap of 182671.00. Regarding current trading prices, GUERF is priced at $22.25, while WHSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas WHSI's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to WHSI's ROE of +0.84%. Regarding short-term risk, GUERF and WHSI have similar daily volatility (0.00).
GUERF vs BLFE Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, BLFE has a market cap of 156683.00. Regarding current trading prices, GUERF is priced at $22.25, while BLFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas BLFE's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to BLFE's ROE of +0.00%. Regarding short-term risk, GUERF is less volatile compared to BLFE. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs QTXB Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, QTXB has a market cap of 118045.00. Regarding current trading prices, GUERF is priced at $22.25, while QTXB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas QTXB's P/E ratio is -0.05. In terms of profitability, GUERF's ROE is N/A, compared to QTXB's ROE of +0.00%. Regarding short-term risk, GUERF is less volatile compared to QTXB. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs CEOS Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, CEOS has a market cap of 90076.00. Regarding current trading prices, GUERF is priced at $22.25, while CEOS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas CEOS's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to CEOS's ROE of +1.18%. Regarding short-term risk, GUERF is less volatile compared to CEOS. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs GMVDF Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, GMVDF has a market cap of 51984.00. Regarding current trading prices, GUERF is priced at $22.25, while GMVDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas GMVDF's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to GMVDF's ROE of N/A. Regarding short-term risk, GUERF and GMVDF have similar daily volatility (0.00).
GUERF vs LANZ Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, LANZ has a market cap of 27690.00. Regarding current trading prices, GUERF is priced at $22.25, while LANZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas LANZ's P/E ratio is 1.00. In terms of profitability, GUERF's ROE is N/A, compared to LANZ's ROE of N/A. Regarding short-term risk, GUERF and LANZ have similar daily volatility (0.00).
GUERF vs INND Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, INND has a market cap of 17576.00. Regarding current trading prices, GUERF is priced at $22.25, while INND trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas INND's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to INND's ROE of +0.32%. Regarding short-term risk, GUERF is less volatile compared to INND. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs ASFX Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, ASFX has a market cap of 17502.00. Regarding current trading prices, GUERF is priced at $22.25, while ASFX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas ASFX's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to ASFX's ROE of +0.00%. Regarding short-term risk, GUERF and ASFX have similar daily volatility (0.00).
GUERF vs MDIT Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, MDIT has a market cap of 8620.00. Regarding current trading prices, GUERF is priced at $22.25, while MDIT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas MDIT's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to MDIT's ROE of -0.99%. Regarding short-term risk, GUERF and MDIT have similar daily volatility (0.00).
GUERF vs SDCCQ Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SDCCQ has a market cap of 4030.00. Regarding current trading prices, GUERF is priced at $22.25, while SDCCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SDCCQ's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to SDCCQ's ROE of -0.61%. Regarding short-term risk, GUERF is less volatile compared to SDCCQ. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs DGEN Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, DGEN has a market cap of 3859.00. Regarding current trading prices, GUERF is priced at $22.25, while DGEN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas DGEN's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to DGEN's ROE of N/A. Regarding short-term risk, GUERF and DGEN have similar daily volatility (0.00).
GUERF vs LFPI Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, LFPI has a market cap of 2042.00. Regarding current trading prices, GUERF is priced at $22.25, while LFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas LFPI's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to LFPI's ROE of -4.85%. Regarding short-term risk, GUERF is less volatile compared to LFPI. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs SVSO Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SVSO has a market cap of 1276.00. Regarding current trading prices, GUERF is priced at $22.25, while SVSO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SVSO's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to SVSO's ROE of +0.17%. Regarding short-term risk, GUERF is less volatile compared to SVSO. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs SEYE Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SEYE has a market cap of 1159.00. Regarding current trading prices, GUERF is priced at $22.25, while SEYE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SEYE's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to SEYE's ROE of N/A. Regarding short-term risk, GUERF and SEYE have similar daily volatility (0.00).
GUERF vs BGMD Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, BGMD has a market cap of 1137.00. Regarding current trading prices, GUERF is priced at $22.25, while BGMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas BGMD's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to BGMD's ROE of +0.00%. Regarding short-term risk, GUERF is less volatile compared to BGMD. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs ADLI Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, ADLI has a market cap of 1039.00. Regarding current trading prices, GUERF is priced at $22.25, while ADLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas ADLI's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to ADLI's ROE of +1.36%. Regarding short-term risk, GUERF is less volatile compared to ADLI. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs VSMD Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, VSMD has a market cap of 801.00. Regarding current trading prices, GUERF is priced at $22.25, while VSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas VSMD's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to VSMD's ROE of +3.15%. Regarding short-term risk, GUERF is less volatile compared to VSMD. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs HRAL Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, HRAL has a market cap of 396.00. Regarding current trading prices, GUERF is priced at $22.25, while HRAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas HRAL's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to HRAL's ROE of +0.13%. Regarding short-term risk, GUERF is less volatile compared to HRAL. This indicates potentially lower risk in terms of short-term price fluctuations for GUERF.
GUERF vs MICRD Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, MICRD has a market cap of 317.00. Regarding current trading prices, GUERF is priced at $22.25, while MICRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas MICRD's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to MICRD's ROE of -0.25%. Regarding short-term risk, GUERF and MICRD have similar daily volatility (0.00).
GUERF vs RGBOQ Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, RGBOQ has a market cap of 97.00. Regarding current trading prices, GUERF is priced at $22.25, while RGBOQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas RGBOQ's P/E ratio is -0.00. In terms of profitability, GUERF's ROE is N/A, compared to RGBOQ's ROE of N/A. Regarding short-term risk, GUERF and RGBOQ have similar daily volatility (0.00).
GUERF vs SECI Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, SECI has a market cap of 31.00. Regarding current trading prices, GUERF is priced at $22.25, while SECI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas SECI's P/E ratio is N/A. In terms of profitability, GUERF's ROE is N/A, compared to SECI's ROE of -0.00%. Regarding short-term risk, GUERF and SECI have similar daily volatility (0.00).
GUERF vs VTEQ Comparison
GUERF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GUERF stands at 281.03M. In comparison, VTEQ has a market cap of 1.00. Regarding current trading prices, GUERF is priced at $22.25, while VTEQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GUERF currently has a P/E ratio of 8.19, whereas VTEQ's P/E ratio is -0.00. In terms of profitability, GUERF's ROE is N/A, compared to VTEQ's ROE of N/A. Regarding short-term risk, GUERF and VTEQ have similar daily volatility (0.00).